Share price and RNS

To view the latest share price data and regulatory news service announcements for Sareum plc please click on the links below.

Sareum Holdings News and Articles from

Proactive Investors logo

26th September 2018
Sareum Holdings Plc (LON:SAR) has selected another candidate molecule from its TYK2 inhibitor programme to take through the clinic, this time as a potential therapy for certain cancers. Earlier this month, the AIM company went with SDC-1801 as a &l…
11th September 2018
Sareum Holdings Plc (LON:SAR) has highlighted the progress made by its in-house and out-licensed drug programmes over the past year. US firm Sierra Oncology, which is the licence holder of Sareum’s SRA737 checkpoint kinase 1 (Chk1) inhibitor …
50
  • @Sareumplc Latest tweet

    Roche's discontinuation of its CHK1 inhibitor, RG7741 (aka Genentech's GDC-0575), means this mechanism is now a two… https://t.co/xq9zzVT44p via @Sareumplc
    View more